Anemia

Jump to navigation Jump to search

For patient information click here

Anemia
ICD-10 D50-D64
ICD-9 280-285
DiseasesDB 663
MedlinePlus 000560
MeSH D000740

WikiDoc Resources for Anemia

Articles

Most recent articles on Anemia

Most cited articles on Anemia

Review articles on Anemia

Articles on Anemia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Anemia

Images of Anemia

Photos of Anemia

Podcasts & MP3s on Anemia

Videos on Anemia

Evidence Based Medicine

Cochrane Collaboration on Anemia

Bandolier on Anemia

TRIP on Anemia

Clinical Trials

Ongoing Trials on Anemia at Clinical Trials.gov

Trial results on Anemia

Clinical Trials on Anemia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Anemia

NICE Guidance on Anemia

NHS PRODIGY Guidance

FDA on Anemia

CDC on Anemia

Books

Books on Anemia

News

Anemia in the news

Be alerted to news on Anemia

News trends on Anemia

Commentary

Blogs on Anemia

Definitions

Definitions of Anemia

Patient Resources / Community

Patient resources on Anemia

Discussion groups on Anemia

Patient Handouts on Anemia

Directions to Hospitals Treating Anemia

Risk calculators and risk factors for Anemia

Healthcare Provider Resources

Symptoms of Anemia

Causes & Risk Factors for Anemia

Diagnostic studies for Anemia

Treatment of Anemia

Continuing Medical Education (CME)

CME Programs on Anemia

International

Anemia en Espanol

Anemia en Francais

Business

Anemia in the Marketplace

Patents on Anemia

Experimental / Informatics

List of terms related to Anemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Anemia (American English) or anæmia/anaemia (British English), from the Greek (Template:Polytonic) (an-haîma) meaning "without blood", is a deficiency of red blood cells (RBCs) and/or hemoglobin. This results in a reduced ability of blood to transfer oxygen to the tissues, causing tissue hypoxia. Since all human cells depend on oxygen for survival, varying degrees of anemia can have a wide range of clinical consequences. Hemoglobin (the oxygen-carrying protein in the red blood cells) has to be present to ensure adequate oxygenation of all tissues and organs. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis).

Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.

There are two major approaches of classifying anemias, the "kinetic" approach which involves evaluating production, destruction and loss, and the "morphologic" approach which groups anemia by red blood cell size. The morphologic approach uses a quickly available and cheap lab test as its starting point (the MCV). On the other hand, focusing early on the question of production may allow the clinician more rapidly to expose cases where multiple causes of anemia coexist.

Signs and symptoms

Symptoms

  • Anemia goes undetected in many people, and symptoms can be vague. The signs and symptoms are similar in different types of anemia. The presentation may vary depending on the hematocrit levels and the general health condition of the patient (age, sex, pregnancy, cardiac conditions, and any other comorbidities) rather than the etiology behind the anemia. A hematocrit level of between 30 - 35 is usually produces no symptoms whereas a fall of heamtocrit levels to 15 - 20 may produce severe symptoms (shortness of breath, syncope). The common presentation can include:
    • Asymptomatic
    • Weakness or fatigue on exertion and on rest (if the hematocrit falls further).
    • Poor concentration
    • Confusion
    • Syncope
    • Shortness of breath (severe anemia)
    • Racing heart (very severe anemia prompts the body to compensate by increasing cardiac output)
    • Pica, the consumption of non-food such as dirt, paper, wax, grass and hair, may be a symptom of iron deficiency anemia, although it occurs often in those who have normal levels of hemoglobin.
    • Chronic anemia may result in behavioral disturbances in children as a direct result of impaired neurological development in infants, and reduced scholastic performance in children of school age. Behavioral disturbances may even surface as an attention deficit disorder.

Signs

Diagnosis

Complete Differential Diagnosis of Causes of Anemia

Macrocytic

Microcytic

Normocytic

Classification

One of the most common systems classifies anemia based upon the size of the red blood cells and the concentration of hemoglobin in the red blood cells:

Mean corpuscular volume (MCV)

MCV is used to distinguish between microcytic, normocytic, and macrocytic anemia.

    • Microcytic: MCV<80
    • Normocytic: MCV 80-100
    • Macrocytic: MCV>100

Mean corpuscular hemoglobin concentration (MCHC)

MCHC is used to distinguish between hypochromic, normochromic, and hyperchromic anemia.

    • Hypochromic: MCHC<33
    • Normochromic: MCHC 33-35
    • Hyperchromic: MCHC>35

Production vs. destruction or loss

The "kinetic" approach to anemia yields what many argue is the most clinically relevant classification of anemia. This classification depends on evaluation of several hematological parameters, particularly the blood reticulocyte (precursor of mature RBCs) count. This then yields the classification of defects by decreased RBC production versus increased RBC destruction and/or loss. Clinical signs of loss or destruction include abnormal peripheral blood smear with signs of hemolysis; elevated LDH suggesting cell destruction; or clinical signs of bleeding, such as guiaic-positive stool, radiographic findings, or frank bleeding.

Here is a simplified schematic of this approach:

 
 
 
 
 
 
 
 
Anemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reticulocyte production index shows inadequate production response to anemia.
 
 
 
Reticulocyte production index shows appropriate response to anemia = ongoing hemolysis or blood loss without RBC production problem.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No clinical findings consistent with hemolysis or blood loss: pure disorder of production.
 
Clinical findings and abnormal MCV: hemolysis or loss and chronic disorder of production*.
 
Clinical findings and normal MCV= acute hemolysis or loss without adequate time for bone marrow production to compensate**.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Macrocytic anemia (MCV>100)
 
Normocytic anemia (80<MCV<100)
 
 
Microcytic anemia (MCV<80)
 
 
 
 

* For instance, sickle cell anemia with superimposed iron deficiency; chronic gastric bleeding with B12 and folate deficiency; and other instances of anemia with more than one cause. ** Confirm by repeating reticulocyte count: ongoing combination of low reticulocyte production index, normal MCV and hemolysis or loss may be seen in bone marrow failure or anemia of chronic disease, with superimposed or related hemolysis or blood loss.

Red blood cell size

In the morphological approach, anemia is classified by the size of red blood cells; this is either done automatically or on microscopic examination of a peripheral blood smear. The size is reflected in the mean corpuscular volume (MCV). If the cells are smaller than normal (under 80 fl), the anemia is said to be microcytic; if they are normal size (80-100 fl), normocytic; and if they are larger than normal (over 100 fl), the anemia is classified as macrocytic. This scheme quickly exposes some of the most common causes of anemia; for instance, a microcytic anemia is often the result of iron deficiency. In clinical workup, the MCV will be one of the first pieces of information available; so even among clinicians who consider the "kinetic" approach more useful philosophically, morphology will remain an important element of classification and diagnosis.

Here is a schematic representation of how to consider anemia with MCV as the starting point:

 
 
 
 
 
 
 
 
 
 
 
Anemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Macrocytic anemia (MCV>100)
 
 
 
 
 
Normocytic anemia (80<MCV<100)
 
 
 
 
 
Microcytic anemia (MCV<80)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
High reticulocyte count
 
 
 
 
 
Low reticulocyte count
 
 
 
 

Other characteristics visible on the peripheral smear may provide valuable clues about a more specific diagnosis; for example, abnormal white blood cells may point to a cause in the bone marrow.

Microcytic anemia

Microcytic anemia is primarily a result of hemoglobin synthesis failure/insufficiency, which could be caused by several etiologies:

  • Heme synthesis defect
  • Globin synthesis defect
    • alpha-, and beta-thalassemia
    • HbE syndrome
    • HbC syndrome
    • and various other unstable hemoglobin diseases
  • Sideroblastic defect
    • Hereditary Sideroblastic anemia
    • Acquired Sideroblastic anemia including lead toxicity
    • Reversible Sideroblastic anemia
  • Iron deficiency anemia is the most common type of anemia overall and it has many causes. RBCs often appear hypochromic (paler than usual) and microcytic (smaller than usual) when viewed with a microscope.
    • Iron deficiency anemia is caused by insufficient dietary intake or absorption of iron to replace losses from menstruation or losses due to diseases.[1] Iron is an essential part of hemoglobin, and low iron levels result in decreased incorporation of hemoglobin into red blood cells. In the United States, 20% of all women of childbearing age have iron deficiency anemia, compared with only 2% of adult men. The principal cause of iron deficiency anemia in premenopausal women is blood lost during menses. Studies have shown that iron deficiency without anemia causes poor school performance and lower IQ in teenage girls. Iron deficiency is the most prevalent deficiency state on a worldwide basis. Iron found in animal meats are more easily absorbed by the body than iron found in non-meat sources. In countries where animal meats are only occasionally available in the diet, iron deficiency anemia is six to eight times more prevalent than in North America and Europe. Iron deficiency is sometimes the cause of abnormal fissuring of the angular (corner) sections of the lips (angular cheilitis).
    • Iron deficiency anemia can also be due to bleeding lesions of the gastrointestinal tract. Fecal occult blood testing, upper endoscopy and lower endoscopy should be performed to identify bleeding lesions. In men and post-menopausal women the chances are higher that bleeding from the gastrointestinal tract could be due to colon polyp or colorectal cancer.
    • Worldwide, the most common cause of iron deficiency anemia is parasitic infestation (hookworm, amebiasis, schistosomiasis and whipworm).[2]
  • Hemoglobinopathies - much rarer (apart from communities where these conditions are prevalent)
    • Hb S Sickle-cell disease
    • Hb C
    • Hb E
    • Hb D-Punjab
    • Hb O-Arab
    • Hb G-Philadelphia
    • Hb Hasharon
    • Hb Korle-Bu
    • Hb Lepore
    • Hb M

A mnemonic commonly used to remember causes of microcytic anemia is TAILS: T - Thalassemia, A - Anemia of chronic disease, I - Iron deficiency anemia, L - Lead toxicity associated anemia, S - Sideroblastic anemia.

Normocytic anemia

Normocytic anaemia occurs when the overall Hb levels are decreased, but the red blood cell size (MCV) remains normal. Causes include:

Macrocytic anemia

  • Megaloblastic anemia is the most common cause of macrocytic anemia.
  • Megaloblastic anemia is due to a deficiency of either vitamin B12, folic acid (or both), or to autoimmune processes that cause deficiency in either, such as pernicious anemia. Deficiency in folate and/or Vitamin B12 can be due either to inadequate intake or insufficient absorption. Folate deficiency normally does not produce neurological symptoms, while B12 deficiency does.
  • Pernicious anemia is an autoimmune condition directed against the parietal cells of the stomach. Parietal cells produce intrinsic factor, required to absorb vitamin B12 from food. Therefore, the destruction of the parietal cells causes a lack of intrinsic factor, leading to poor absorption of vitamin B12. Pernicious anemia can also be caused by removal of the functional portion of the stomach, such as during gastric bypass surgery. Therefore one must always be aware of anemia following this procedure.
  • Alcoholism causes a macrocytosis, although not specifically anemia
  • Methotrexate, zidovudine, and other drugs that inhibit DNA replication. This is the most common etiology in nonalcoholic patients.

Macrocytic anemia can be further divided into "megaloblastic anemia" or "non-megaloblastic macrocytic anemia". The cause of megaloblastic anemia is primarily a failure of DNA synthesis with preserved RNA synthesis, which result in restricted cell division of the progenitor cells. The megaloblastic anemias often present with neutrophil hypersegmentation (6-10 lobes). The non-megaloblastic macrocytic anemias have different etiologies (i.e. there is unimpaired DNA globin synthesis,) which occur, for example in alcoholism.

In addition to the non-specific symptoms of anemia, specific features of vitamin B12 deficiency include peripheral neuropathy and subacute combined degeneration of the cord with resulting balance difficulties from posterior column spinal cord pathology. Other features may include a smooth, red tongue, (glossitis).

The treatment for vitamin B12-deficient anemia was first devised by William Murphy who bled dogs to make them anemic and then fed them various substances to see what (if anything) would make them healthy again. He discovered that ingesting large amounts of liver seemed to cure the disease. George Minot and George Whipple then set about to chemically isolate the curative substance and ultimately were able to isolate the vitamin B12 from the liver. All three shared the 1934 Nobel Prize in Medicine.[3]

Dimorphic anemia

When two causes of anemia act simultaneously, e.g., macrocytic hypochromic, due to hookworm infestation leading to deficiency of both iron and vitamin B12 or folic acid or following a blood transfusion more than one abnormality of red cell indices may be seen. Evidence for multiple causes appears with an elevated RBC distribution width (RDW), which suggests a wider-than-normal range of red cell sizes.

Heinz body anemia

Heinz bodies are an abnormality that form on the cells in this condition. This form of anemia may be brought on by taking certain medications; it is also triggered in cats by eating onions.[4] or acetaminophen (Tylenol). It can be triggered in dogs by ingesting onions or zinc, and in horses by ingesting dry Red Maple leaves.

Specific anemias

Possible complications

  • Angina, myocardial infarction (commonest cause of death)
  • High output failure
  • brittle or rigid fingernails
  • Cold intolerance (occurs in one in five patients with iron deficiency anemia, and becomes visible through numbness and tingling)
  • Impaired immune function
  • Behavioral disturbances in children

Anemia during pregnancy

Anemia affects 20% of all females of childbearing age in the United States. Because of the subtlety of the symptoms, women are often unaware that they have this disorder, as they attribute the symptoms to the stresses of their daily lives. Possible problems for the fetus include increased risk of growth retardation, prematurity, intrauterine death, rupture of the amnion and infection.

During pregnancy, women should be especially aware of the symptoms of anemia, as an adult female loses an average of two milligrams of iron daily. Therefore, she must intake a similar quantity of iron in order to make up for this loss. Additionally, a woman loses approximately 500 milligrams of iron with each pregnancy, compared to a loss of 4-100 milligrams of iron with each period. Possible consequences for the mother include cardiovascular symptoms, reduced physical and mental performance, reduced immune function, tiredness, reduced peripartal blood reserves and increased need for blood transfusion in the postpartum period.

Diet and anemia

Consumption of food rich in iron is essential to prevention of iron deficiency anemia.

Some foods rich in iron include: Canned clams; Fortified dry cereals; Cooked oysters; Organ meats (liver, giblets); *Fortified instant cooked cereals; Soybeans, mature, cooked; Pumpkin and squash seed kernels, roasted; White beans; Blackstrap molasses, 1 Tbsp; Lentils, cooked; Spinach, cooked from fresh; Beef (chuck); Kidney beans; Sardines; Beef(rib); Chickpeas; Duck, meat only; Lamb shoulder; Prune juice.[1]

Certain foods have been found to interfere with iron absorption in the gastrointestinal tract, and these foods should be avoided in persons with established iron deficiency. They include tea, coffee, wheat bran, rhubarb, chocolate, chewing gum, red wine, and dairy products.[5]

Diagnosis

Laboratory Findings

Initial Studies

Follow-up Studies Depending Upon Clinical Suspicion

Treatment of Anemia

If hemodynamic compromise is present, then immediate intervention is required which includes:

  • Administration of O2 as needed
  • Iron, folate, vitamin B12 supplements as necessary
  • IV fluids for maintenance of blood pressure
  • For hemoglobins <8 gm/dl, blood transfusions are indicated
  • Establishment of two large-bore IVs for cases of ongoing acute blood loss

There are many different treatments for anemia and the treatment depends on severity and the cause.

Iron deficiency from nutritional causes is rare in non-menstruating adults (men and post-menopausal women). The diagnosis of iron deficiency mandates a search for potential sources of loss such as gastrointestinal bleeding from ulcers or colon cancer. Mild to moderate iron deficiency anemia is treated by iron supplementation with ferrous sulfate or ferrous gluconate. Vitamin C may aid in the body's ability to absorb iron.

Vitamin supplements given orally (folic acid) or subcutaneously (vitamin b-12) will replace specific deficiencies.

In anemia of chronic disease, anemia associated with chemotherapy, or anemia associated with renal disease, some clinicians prescribe recombinant erythropoietin, epoetin alfa, to stimulate red cell production.

In severe cases of anemia, or with ongoing blood loss, a blood transfusion may be necessary.

Blood transfusions for anemia

Doctors attempt to avoid blood transfusion in general, since multiple lines of evidence point to increased adverse patient clinical outcomes with more intensive transfusion strategies. The physiological principle that reduction of oxygen delivery associated with anemia leads to adverse clinical outcomes is balanced by the finding that transfusion does not necessarily mitigate these adverse clinical outcomes.

In severe, acute bleeding, transfusions of donated blood are often lifesaving. Improvements in battlefield casualty survival is attributable, at least in part, to the recent improvements in blood banking and transfusion techniques.

Transfusion of the stable but anemic hospitalized patient has been the subject of numerous clinical trials, and transfusion is emerging as a deleterious intervention.

Four randomized controlled clinical trials have been conducted to evaluate aggressive versus conservative transfusion strategies in critically ill patients. All four of these studies failed to find a benefit with more aggressive transfusion strategies. [6] [7] [8] [9]

In addition, at least two retrospective studies have shown increases in adverse clinical outcomes with more aggressive transfusion strategies. [10] [11]

On the whole, these studies suggest that aggressive transfusions, at least for hospitalized patients, may at best not improve any clinical parameter, and at worst lead to adverse outcomes.

A recent report suggests that the culprit is the depletion of nitric oxide, an important vasodilator, in banked blood. The theory is that the transfusion of nitric oxide-depleted blood causes systemic vasoconstriction, and exacerbates hypoxia in tissues at risk.[12]

References

See also

References

  1. ↑ 1.0 1.1 Recommendations to Prevent and Control Iron Deficiency in the United States MMWR 1998;47 (No. RR-3) p. 5
  2. ↑ Iron Deficiency Anaemia: Assessment, Prevention, and Control: A guide for programme managers
  3. ↑ Physiology or Medicine 1934 - Presentation Speech
  4. ↑ Onions are Toxic to Cats
  5. ↑ What causes iron deficiency?
  6. ↑ Hébert PC, Wells G, Blajchman MA; et al. (1999). "A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group". N. Engl. J. Med. 340 (6): 409–17. PMID 9971864.
  7. ↑ Bush RL, Pevec WC, Holcroft JW (1997). "A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients". Am. J. Surg. 174 (2): 143–8. PMID 9293831.
  8. ↑ Bracey AW, Radovancevic R, Riggs SA; et al. (1999). "Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome". Transfusion. 39 (10): 1070–7. PMID 10532600.
  9. ↑ McIntyre LA, Fergusson DA, Hutchison JS; et al. (2006). "Effect of a liberal versus restrictive transfusion strategy on mortality in patients with moderate to severe head injury". Neurocritical care. 5 (1): 4–9. PMID 16960287.
  10. ↑ Corwin HL, Gettinger A, Pearl RG; et al. (2004). "The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States". Crit. Care Med. 32 (1): 39–52. doi:10.1097/01.CCM.0000104112.34142.79. PMID 14707558.
  11. ↑ Vincent JL, Baron JF, Reinhart K; et al. (2002). "Anemia and blood transfusion in critically ill patients". JAMA. 288 (12): 1499–507. PMID 12243637.
  12. ↑ MEDICAL SCIENCES S-nitrosohemoglobin deficiency: A mechanism for loss of physiological activity in banked blood James D. Reynolds*, Gregory S. Ahearn{dagger}, Michael Angelo{dagger}, Jian Zhang{dagger}, Fred Cobb{dagger},{ddagger}, and Jonathan S. Stamler Published online before print October 11, 2007 Proc. Natl. Acad. Sci. USA, 10.1073/pnas.0707958104 Accessed 10/15/07

ar:فقر دم bn:রক্তশূন্যতা bs:Anemija bg:Анемия ca:Anèmia cs:Chudokrevnost da:Anæmi de:Anämie et:Aneemia eo:Anemio eu:Anemia fa:کم‌خونی ko:빈혈 id:Anemia ia:Anemia it:Anemia he:אנמיה ku:Anemî la:Anaemia lt:Anemija ms:Penyakit anemia nl:Bloedarmoede no:Anemi nn:Anemi sq:Anemia simple:Anemia sk:Anémia sr:Анемија fi:Anemia sv:Anemi uk:Анемія bat-smg:Anemėjė


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Anemia&oldid=649801"